The OBR Consulting Team
Dan founded OBR in June 2011 out of frustration with the lack of academic / industry ties in the life sciences. Since then he's led OBR's expansion from Oxford across the UK, and to America, Singapore and Hong Kong - and now to over 20,000 members, and partnerships with the world's leading pharmaceutical companies. He also founded Marblar, a VC-backed product development company based in London that turns science into products. Partners include NASA, Penn, and Northwestern University.
Originally from Miami, Dan's a dual-PhD student at Oxford and The Scripps Research Research Institute in California. He has an unhealthy addiction to political news and is rumored to have copious amounts of pop music on his iPod. (An allegation he vehemently denies.)
Jeroen is a postdoctoral fellow at Stanford University studying complex interactions of the human immune system. He received his MSc in Medical Biology from Leiden University. After working for a patent office, he completed a PhD in Immunogenetics at the Dutch Biomedical Primate Research Centre, which specializes in pre-clinical vaccine research and drug development. Jeroen is excited to be creating meaningful partnerships between the academic, biotechnology and investment communities in the Bay Area.
Laura is a PhD candidate in Bioengineering at Stanford University working on molecular imaging of circulating tumor cells in breast cancer. She received a MSc in Biomedical Engineering from ETH Zurich and a MSc in Engineering/Diplome d'Ingenieur from Ecole Centrale Paris, and worked as a scientific associate at Novartis. Laura is excited to be tackling innovation and entrepreneurship-related challenges at the intersection of academia and industry.
Peter obtained a PhD from Durham University in 2012. He is currently undertaking an EPSRC Doctoral Prize Fellowship at the University of Manchester, focusing on the development of novel luminescent biosensors based on a combination of enzymes and rare-earth upconversion nanoparticles. Besides academic research, additional interests include science communication and consulting.
Qize Ding is a 3rd year PhD student at Imperial College London. His research is on the high-throughput screening and isolation of apoptosis inducers against certain mutations in tumour transformation scenarios. He obtained a BSc in Biochemistry and a Masters in Immunology at Imperial College London. He is has a strong interest in the business consulting for the biotechnology and pharmaceutical industries.
Monika is a postdoctoral research associate at the Sanford-Burnham Medical Research Institute. She received her PhD from the University of North Carolina at Chapel Hill. Her research aims to better understand how host innate immune signaling restricts viral infection, with the ultimate goal of identifying potential therapeutic targets. Monika is excited to foster interactions between San Diego’s academic and biotech communities through productive consulting collaborations.
Monika D. Polewski is a CIRM (California Institute of Regenerative Medicine) predoctoral fellow in the Department of Neurosciences at City of Hope’s Irell and Manella Graduate School of Biological Sciences. Her research focuses on novel therapeutics for the treatment of glioma as well as neuroprotective mechanisms in neural stem cells. She is also a graduate of the Bioscience Management Certificate Program at the Keck Graduate Institute where she acquired business, finance and management education tailored toward the necessary skills needed in the life science industry. Monika has prior experience working as an independent contractor and consultant in biotech and is eager to foster fruitful relationships between academia and industry for the OBR-LA chapter.
Brooke is a PhD biologist with a background in chemical engineering and consulting. As a postdoctoral fellow at Stanford University School of Medicine she is identifying essential serine hydrolases that could be therapeutic targets in the parasite responsible for malaria, Plasmodium falciparum. Her passion is to leverage her unique combination of technical and business experience towards product and business development.
Priya is a postdoctoral scholar at the California Institute of Technology working on glycosylated proteins in cancer biology. She previously got her PhD from the Huntsman Cancer Institute at University of Utah. She is interested in integrating scientific and business communities to promote sound and successful start ups ideas.
Bhavaani is a Cell Biologist with background in Pharmaceutical Sciences. As a Postdoctoral fellow at UCLA, she is conducting research to establish the importance of neuropeptides in Multiple Sclerosis. Apart from research, she is actively involved with the business center to work on technology commercialization. Through OBR, she wishes to learn to translate science to the commercial market.
Nikola is a third year PhD student at the MRC Laboratory of Molecular Biology and his research is focused on the biochemistry of Wnt signal transduction and its deregulation in colon cancer. He is interested in the intersection of business and science, especially in how companies use scientific innovation and business processes to deliver real impact for people.